Inhibition of activation of lymphokine-activated killer cells in vitro by the heparin preservative benzyl alcohol.
D001592:Benzyl Alcohols / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000276:immunology*; D007694:Killer Cells, Natural / Q000187:drug effects*; D008213:Lymphocyte Activation / Q000187:drug effects*
D001592:Benzyl Alcohols; D001593:Benzyl Compounds; D007376:Interleukin-2; D006493:Heparin